(Updated - August 10, 2026 9:22 AM EDT)

Stifel analyst Paul Matteis downgraded Sionna Therapeutics (NASDAQ: SION) from Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Downgrades